Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for ARDS in mechanically ventilated ICU patients
IRCT20200425047201N1Phase 2Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of acetylcysteine in acute respiratory distress syndrome (ARDS) (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: PaO2/FiO2 ratio and PEEP. Started Mar 2019; status: completed.
02
Drugs
acetylcysteine
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on IRCT20200425047201N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200425047201N1.